Skip to main content
Fig. 1 | Renal Replacement Therapy

Fig. 1

From: Everolimus improved renal function without reducing the size of a kidney angiomyolipoma in a patient with tuberous sclerosis complex: a case report

Fig. 1

Changes in eGFR with everolimus treatment. The rate of Cr-eGFR decline was − 5.6 mL/min/1.73 m2 per year before initiation of everolimus treatment. After the initiation of everolimus treatment, the Cr-eGFR recovered to 20.1 mL/min/1.73 m2 after increasing by 4.57 mL/min/1.73 m2 per year. Cr-eGFR, creatinine-based estimated glomerular filtration rate

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us